Published in Physician Law Weekly, February 23rd, 2005
Net income included a charge of $3.1 million ($0.10 per diluted share) related to the company's previously communicated decision to discontinue future product development and investments in the semiconductor lithography market within its Lambda Physik subsidiary.
Net income also included a tax benefit of $0.5 million ($0.02 per diluted share) related to federal tax law changes enacted in the current quarter.
Sales and net loss for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly